Analyst firms · Morgan Stanley · CLX
Morgan Stanley CLX price target and rating history
Clorox Company (CLX) · Consumer Discretionary
Morgan Stanley rates Clorox Company (CLX) Equal-Weight with a $130 price target, as of its latest action on Oct 17, 2022. It has published 4 rating actions on CLX since August 2021, including 1 upgrade and 0 downgrades.
- Current rating
- Equal-Weight
- Price target
- $130
- Median target, all firms
- Too few
- Actions on CLX
- 4
Morgan Stanley price target on CLX
Every Morgan Stanley rating on CLX
- Oct 17, 2022
- Feb 4, 2022
- Oct 13, 2021
- Aug 4, 2021
How other firms rate CLX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Evercore ISI | In-line | $99 | Nov 2, 2026 |
| Jefferies | Hold | $98 | Jul 28, 2026 |
| BNP Paribas Exane | Neutral | Feb 11, 2026 |
Questions about Morgan Stanley and CLX
- What is Morgan Stanley's price target for CLX?
- Morgan Stanley's latest stated price target for Clorox Company (CLX) is $130, from its action on Oct 17, 2022.
- What is Morgan Stanley's rating on CLX?
- Morgan Stanley rates CLX Equal-Weight, a neutral rating, as of Oct 17, 2022.
- When did Morgan Stanley last change its view on CLX?
- On Oct 17, 2022, Morgan Stanley upgrades to Equal-Weight from Underweight, price target $130.
More CLX rating histories
- Jefferies4
- Barclays3
- Wells Fargo4
- Citigroup4
- DA Davidson5
- J.P. Morgan3
- UBS4
- Atlantic Equities3
- Deutsche Bank5
- Credit Suisse4
All Morgan Stanley ratingsCLX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.